No immediate trading implications. Monitor for any unexpected opposition or shareholder activism ahead of the vote, though none is indicated in this filing. The next material event to watch is the company's 2025 Form 10-K, referenced in the proxy materials.
Price Chart
Executive Summary
Cumberland Pharmaceuticals Inc. (CPIX) filed a Definitive Additional Proxy Statement (DEFA14A) for its 2026 Annual Meeting of Shareholders, scheduled for April 21, 2026. The filing solicits votes on the re-election of two director nominees (Kenneth Krogulski and Caroline Young), ratification of the appointment of Carr, Riggs Ingram, L.L.C. as independent auditors, advisory approval of executive compensation, and the frequency of future advisory votes on executive pay. The board recommends voting in favor of all proposals.
Key Facts
- Annual meeting date: April 21, 2026
- Record date for voting: February 27, 2026
- Director nominees: Kenneth Krogulski and Caroline Young
- Proposal to ratify Carr, Riggs Ingram, L.L.C. as independent auditors
- Advisory vote on executive compensation (say-on-pay)
- Advisory vote on frequency of say-on-pay votes (board recommends every three years)
- Filed by the registrant (company management)
Financial Impact
No direct financial impact from the proxy proposals
Risk Factors
- Low risk of shareholder opposition given routine nature of proposals
- Potential for future governance concerns if executive compensation becomes excessive relative to performance
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001087294-26-000027 |
| Document: 0001087294-26-000027-index-headers.html | 0001087294-26-000027 |
| Document: 0001087294-26-000027-index.html | 0001087294-26-000027 |
| Document: 0001087294-26-000027.txt | 0001087294-26-000027 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 8-K | $5.22 | awaiting T+1 | — | $4.35 (−16.67%) |
Oct 23, 2026 2d ago | 8-K | $8.46 | awaiting T+1 | — | $4.35 (−48.58%) |
Aug 28, 2026 8w ago | 8-K | $6.69 $6.56 | ▲ +1.94% | ▲ +1.26% | $4.35 (+34.98%) |
Jul 13, 2026 15w ago | Press Release | $6.54 $6.99 | ▲ +6.80% | ▲ +6.45% | $4.35 (−33.49%) |
May 26, 2026 21w ago | DEFM14A | $5.77 $5.86 | ▲ +1.56% | ▲ +1.55% | $4.35 (−24.61%) |
Apr 23, 2026 26w ago | DEFA14A / 8-K | $3.90 $4.06 | ▲ +4.10% | ▲ +3.32% | $4.35 (+11.54%) |
Mar 9, 2026 32w ago | DEFA14A | $3.16 $3.08 | ▼ −2.53% | ▼ −2.43% | $4.35 (+37.66%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers